Assure (OTCMKTS:IONM) vs. Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Critical Contrast

Insider and Institutional Ownership

3.3% of Assure shares are held by institutional investors. Comparatively, 87.8% of Defiance Daily Target 2X Long LMND ETF shares are held by institutional investors. 3.8% of Assure shares are held by insiders. Comparatively, 6.6% of Defiance Daily Target 2X Long LMND ETF shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Assure and Defiance Daily Target 2X Long LMND ETF”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$250,000.00	0.01	-$26.08 million	($56.12)	0.00
Defiance Daily Target 2X Long LMND ETF	$437.66 million	0.01	$15.17 million	$0.51	26.96

Defiance Daily Target 2X Long LMND ETF has higher revenue and earnings than Assure. Assure is trading at a lower price-to-earnings ratio than Defiance Daily Target 2X Long LMND ETF, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Assure has a beta of 198.15, meaning that its share price is 19,715% more volatile than the S&P 500. Comparatively, Defiance Daily Target 2X Long LMND ETF has a beta of -10.11, meaning that its share price is 1,111% less volatile than the S&P 500.

Profitability

This table compares Assure and Defiance Daily Target 2X Long LMND ETF’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Assure	N/A	N/A	N/A
Defiance Daily Target 2X Long LMND ETF	5.39%	4.66%	2.91%

Summary

Defiance Daily Target 2X Long LMND ETF beats Assure on 10 of the 11 factors compared between the two stocks.

About Assure

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.

About Defiance Daily Target 2X Long LMND ETF

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.